ImmunityBio Completes Enrollment in Phase 2 ANKTIVA® Trial for Bladder Cancer
Promising Results for BCG-naïve NMIBC Patients Why are new treatment options for non-muscle invasive bladder cancer (NMIBC) crucial for patient outcomes? ImmunityBio a commercial-stage immunotherapy company, has completed enrollment in…
Evox Therapeutics Partners with RSRT to Develop Gene Editing Treatment for Rett Syndrome
Collaboration Aims to Overcome Delivery Challenges for Neurological Disorders Why has gene editing for Rett syndrome remained elusive despite its potential to reverse symptoms? Evox Therapeutics Ltd (Evox), a biotechnology…
Zai Lab Reports Strong 2025 Financials and Advances Global Oncology Pipeline
Zai Lab’s 2025 Revenue Grows 17% YoY, Paving the Way for 2026 Oncology and Immunology Milestones What does the future hold for global oncology and immunology advancements? Zai Lab Limited…
ViiV Healthcare Unveils Promising Long-Acting HIV Treatments with VH184 and VH499
New Data Show Potential for Twice-Yearly Dosing, Enhancing Treatment Options for HIV Patients Why is the current landscape of HIV treatment ripe for innovation? ViiV Healthcare, a global specialist HIV…
Niagen Bioscience Strengthens IP Moat with New Patent for NAD+ IV and Injectable Formulations
Patent Expands Niagen’s Leadership in NAD+ Delivery, Supporting Faster and Safer Treatments Why is the race for intellectual property in the NAD+ market heating up? Niagen Bioscience, Inc. a global…
Atlanta Hawks and Ressler Gertz Family Foundation Donate $150,000 to Prostate Cancer Research
Hawks and Ressler Gertz Family Foundation Boost Prostate Cancer Research with $150,000 Donation Why is prostate cancer awareness and research crucial in the sports industry? The Atlanta Hawks Foundation, in…
Alpha Cognition Enrolls First Patient in BEACON Study for ZUNVEYL
Real-World Impact of ZUNVEYL in Long-Term Care to Be Assessed What does the future hold for Alzheimer’s disease treatment in long-term care settings? Alpha Cognition Inc. a biopharmaceutical company focused…
NYU Abu Dhabi and RTW Investments Partner to Advance Healthcare Innovation in the Middle East
Strategic Collaboration to Convene Global Investors and Leaders for Healthcare Advancement Why is the Middle East emerging as a critical hub for healthcare innovation? NYU Abu Dhabi and RTW Investments,…
Asahi Kasei Pharma Strengthens Drug Discovery Pipeline with Alchemedicine
Strategic License Agreement Advances Novel Compounds for Autoimmune Diseases Why are autoimmune diseases still a significant challenge for pharmaceutical companies? Asahi Kasei Pharma, a global leader in drug development, is…
Chemify and Sanacor Partner to Accelerate Mitochondrial Dysfunction Therapies
Chemify and Sanacor Join Forces to Tackle Diabetic Cardiovascular Disease Why is the discovery of new therapies for diabetic cardiovascular disease so critical? Chemify, a deep-tech pioneer in Chemputation, and…
Enveric Biosciences Secures Patent Protection Amidst Industry Challenges
Enveric Biosciences Overcomes Legal Hurdles to Protect Innovative Neuroplastogenic Therapeutics What does the withdrawal of a patent challenge mean for a biotech company’s intellectual property and future innovations? Enveric Biosciences…
Kivu Bioscience Advances KIVU-305 into Clinical Trials for CEACAM5-Expressing Cancers
Kivu Bioscience Secures HREC Approval and CTN Clearance for Next-Generation ADC Why are next-generation antibody-drug conjugates (ADCs) crucial for advancing cancer treatments? Kivu Bioscience, a clinical-stage biotechnology company based in…